Thomas Story & Son LLC Abbott Laboratories Transaction History

Thomas Story & Son LLC

$239 Million
Q4 2024

A detailed history of Thomas Story & Son LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Thomas Story & Son LLC holds 65,589 shares of ABT stock, worth $8.99 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares

65,589

Previous 66,544 1.44%

Holding current value

$8.99 Million

Previous $7.59 Million 2.21%

% of portfolio

3.11%

Previous 3.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$111.93 - $119.39 $106,893 - $114,017	-955 Reduced 1.44%	65,589 $7.42 Million
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $2.22 Million - $2.62 Million	22,219 Added 50.13%	66,544 $7.59 Million
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $856,205 - $955,740	-8,500 Reduced 16.09%	44,325 $4.61 Million
Q4 2023 Feb 29, 2024	SELL	$90.19 - $110.4 $6,313 - $7,728	-70 Reduced 0.13%	52,825 $5.81 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $140,906 - $169,064	-1,475 Reduced 2.71%	52,895 $5.12 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $6,550 - $7,298	65 Added 0.12%	54,370 $5.93 Million
Q1 2023 Apr 21, 2023	BUY	$96.86 - $114.01 $3,390 - $3,990	35 Added 0.06%	54,305 $5.5 Million
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $182,039 - $213,560	-1,915 Reduced 3.41%	54,270 $5.96 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $124,239 - $143,846	-1,284 Reduced 2.23%	56,185 $5.44 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $2.56 Million - $3.1 Million	25,102 Added 77.55%	57,469 $6.24 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $111,169 - $135,564	975 Added 3.11%	32,367 $3.83 Million
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $268,607 - $328,894	-2,325 Reduced 6.9%	31,392 $4.42 Million
Q3 2021 Oct 22, 2021	BUY	$116.66 - $129.06 $7,699 - $8,517	66 Added 0.2%	33,717 $3.98 Million
Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $133,824 - $157,530	-1,265 Reduced 3.62%	33,651 $3.9 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $6,095 - $7,180	56 Added 0.16%	34,916 $4.18 Million
Q3 2020 Oct 23, 2020	SELL	$91.64 - $111.29 $855,459 - $1.04 Million	-9,335 Reduced 21.12%	34,860 $3.79 Million
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $1,914 - $2,450	-25 Reduced 0.06%	44,195 $4.04 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $99,879 - $112,925	-1,775 Reduced 3.86%	44,220 $2.65 Million
Q4 2017 Jan 29, 2018	SELL	$53.68 - $57.47 $335,500 - $359,187	-6,250 Reduced 11.96%	45,995 $2.63 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $2.51 Million - $2.8 Million	52,245	52,245 $2.79 Million

Others Institutions Holding ABT

# of Institutions

3,372

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $240B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas Story & Son LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thomas Story & Son LLC with notifications on news.

Account

Thomas Story & Son LLC Abbott Laboratories Transaction History